HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dimitrios Bafaloukos Selected Research

Endometrial Neoplasms (Endometrial Cancer)

10/2008Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
7/2008Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dimitrios Bafaloukos Research Topics

Disease

40Neoplasms (Cancer)
03/2023 - 03/2003
36Breast Neoplasms (Breast Cancer)
12/2023 - 07/2005
20Melanoma (Melanoma, Malignant)
12/2023 - 12/2002
11Colorectal Neoplasms (Colorectal Cancer)
12/2019 - 03/2003
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2023 - 02/2007
9Neoplasm Metastasis (Metastasis)
03/2022 - 09/2004
8Carcinoma (Carcinomatosis)
05/2017 - 06/2002
6Disease Progression
01/2018 - 07/2005
4Colonic Neoplasms (Colon Cancer)
12/2019 - 01/2011
3Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2014
2Drug-Related Side Effects and Adverse Reactions
01/2020 - 01/2013
2Anemia
02/2016 - 06/2008
2Ovarian Neoplasms (Ovarian Cancer)
01/2010 - 10/2008
2Endometrial Neoplasms (Endometrial Cancer)
10/2008 - 07/2008
2Febrile Neutropenia
07/2005 - 06/2004
1Rupture
12/2023
1COVID-19
03/2023
1Gastritis
11/2022
1Periodontal Diseases (Periodontal Disease)
01/2020
1Inflammation (Inflammations)
01/2020
1Colitis
11/2019

Drug/Important Bio-Agent (IBA)

17ParaffinIBA
12/2019 - 11/2006
17Paclitaxel (Taxol)FDA LinkGeneric
07/2015 - 06/2002
15Messenger RNA (mRNA)IBA
03/2023 - 11/2006
14Formaldehyde (Formol)FDA Link
12/2019 - 07/2009
13Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2009
12Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2008
10Trastuzumab (Herceptin)FDA Link
10/2022 - 10/2012
10ErbB Receptors (EGF Receptor)IBA
01/2022 - 07/2005
10AnthracyclinesIBA
01/2022 - 07/2008
10Fluorouracil (Carac)FDA LinkGeneric
12/2019 - 03/2003
8Epirubicin (Ellence)FDA LinkGeneric
12/2023 - 07/2008
8Carboplatin (JM8)FDA LinkGeneric
06/2010 - 09/2004
7Taxoids (Taxanes)IBA
01/2022 - 10/2004
7Cisplatin (Platino)FDA LinkGeneric
02/2015 - 06/2002
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 11/2006
6Leucovorin (Folinic Acid)FDA Link
12/2019 - 03/2003
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2023 - 04/2012
5Tyrosine Kinase InhibitorsIBA
01/2021 - 07/2005
5Hormones (Hormone)IBA
01/2020 - 06/2006
5Bevacizumab (Avastin)FDA Link
01/2020 - 09/2011
5Irinotecan (Camptosar)FDA LinkGeneric
12/2019 - 03/2003
5Monoclonal AntibodiesIBA
11/2018 - 10/2008
5RNA (Ribonucleic Acid)IBA
07/2015 - 11/2006
4Docetaxel (Taxotere)FDA Link
12/2023 - 01/2006
4Immune Checkpoint InhibitorsIBA
06/2023 - 02/2015
4NivolumabIBA
06/2023 - 01/2019
4human ERBB2 proteinIBA
10/2022 - 06/2012
4thiamine triphosphorate (TTP)IBA
01/2022 - 01/2005
4LigandsIBA
01/2022 - 06/2012
4Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2019 - 07/2005
4Vascular Endothelial Growth Factor CIBA
01/2018 - 11/2012
4Phenobarbital (Luminal)FDA Link
01/2017 - 01/2014
4DNA (Deoxyribonucleic Acid)IBA
05/2016 - 02/2006
4InterferonsIBA
01/2016 - 12/2002
4Methotrexate (Mexate)FDA LinkGeneric
07/2015 - 04/2012
4Estrogen ReceptorsIBA
11/2012 - 07/2009
4Progesterone Receptors (Progesterone Receptor)IBA
11/2012 - 07/2009
4GemcitabineFDA Link
10/2008 - 09/2004
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2023 - 01/2019
3Cetuximab (Erbitux)FDA Link
05/2014 - 05/2011
3PlatinumIBA
01/2010 - 09/2004
3liposomal doxorubicin (Doxil)FDA Link
01/2010 - 06/2004
3Interferon alpha-2 (Roferon-A)FDA Link
02/2009 - 05/2004
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2008 - 07/2005
3Gefitinib (Iressa)FDA Link
10/2008 - 07/2005
2dabrafenibIBA
12/2023 - 05/2021
2trametinibIBA
12/2023 - 05/2021
2VaccinesIBA
03/2023 - 03/2022
2Protein Isoforms (Isoforms)IBA
04/2021 - 12/2019
2IpilimumabIBA
11/2019 - 01/2019
2Somatomedin Receptors (Somatomedin Receptor)IBA
11/2018 - 01/2014
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
09/2015 - 07/2015
2Temozolomide (Temodar)FDA LinkGeneric
02/2015 - 01/2005
2PTEN Phosphohydrolase (PTEN Phosphatase)IBA
01/2015 - 05/2014
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
06/2012 - 07/2009
2taxaneIBA
09/2011 - 07/2005
2Platinum Compounds (Compounds, Platinum)IBA
10/2008 - 07/2008
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2008 - 08/2008
2Topotecan (Hycamtin)FDA LinkGeneric
10/2008 - 01/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2008 - 06/2004
21-dodecylpyridoxal (PLD)IBA
07/2005 - 06/2004
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2023
1mRNA VaccinesIBA
03/2023
1Neoplasm Antigens (Tumor Antigens)IBA
03/2023
1trastuzumab deruxtecanIBA
02/2023
1Immunoconjugates (Immunoconjugate)IBA
02/2023
1antineoplaston A10 (A 10)IBA
11/2022
1COVID-19 VaccinesIBA
03/2022
1Therapeutic UsesIBA
03/2022
1AfatinibIBA
01/2021
1Zoledronic Acid (Zometa)FDA Link
01/2020
1Cyclin-Dependent Kinase 4IBA
01/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020
1Interleukin-17 (Interleukin 17)IBA
01/2020

Therapy/Procedure

33Drug Therapy (Chemotherapy)
12/2023 - 03/2003
18Therapeutics
12/2023 - 03/2003
14Adjuvant Chemotherapy
11/2022 - 03/2003
3Immunotherapy
03/2023 - 02/2006
2Precision Medicine
01/2020 - 05/2011